Asset
Albuterol Sulfate
AstraZeneca PLC Ordinary Shares
Revenue
No revenue reported in loaded filings.
Clinical trials (1)
| NCT ID | Phase | Status | Start | Completion | Sponsor name | Title |
|---|---|---|---|---|---|---|
| NCT04159519 | phase4 | completed | 2020-07-27 | 2023-01-31 | AstraZeneca | A Study to Assess the Reduction of Daily Maintenance ICS/LABA Treatment Towards Anti-Inflammatory Reliever Treatment in Patients With Severe Eosinophilic Asthma Treated With Benralizumab |
FDA applications (1)
| Application | Type | Applicant |
|---|---|---|
| NDA 214070 | NDA | ASTRAZENECA PHARMACEUTICALS LP |
Marketed products (1)
- AIRSUPRA